Medicinal Chemicals and Botanical Products - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Medicinal industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Medicinal Chemicals and Botanical Products - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Medicinal Chemicals and Botanical Products
Corporate Insider Buy Sell Ratio (Insider Count) - Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-04-24 NAGE / Niagen Bioscience, Inc. 4 Fried Robert N M - Exercise D 2.61 20,000
2026-04-23 USNA / USANA Health Sciences, Inc. 4 Fleming John Turman M - Exercise D 1,057
2026-04-23 USNA / USANA Health Sciences, Inc. 4 Pelosi Peggie M - Exercise D 1,057
2026-04-23 USNA / USANA Health Sciences, Inc. 4 Nixon J Scott M - Exercise D 1,057
2026-04-23 USNA / USANA Health Sciences, Inc. 4 Winssinger Frederic J M - Exercise D 1,057
2026-04-23 USNA / USANA Health Sciences, Inc. 4 WOOD TIMOTHY E M - Exercise D 1,057
2026-04-23 USNA / USANA Health Sciences, Inc. 4 FULLER GILBERT A M - Exercise D 1,057
2026-04-23 USNA / USANA Health Sciences, Inc. 4 Ding Xia M - Exercise D 1,057
2026-04-23 USNA / USANA Health Sciences, Inc. 4 Ding Xia F - Taxes D 19.24 -391
2026-04-23 USNA / USANA Health Sciences, Inc. 4 WOOD TIMOTHY E F - Taxes D 19.24 -264
2026-04-23 USNA / USANA Health Sciences, Inc. 4 Pelosi Peggie F - Taxes D 19.24 -668
2026-04-21 TLRY / Tilray Brands, Inc. 4 Hopkinson David G. S - Sale D 6.94 -33,556
2026-04-21 SNYR / Synergy CHC Corp. 4 Kaushal Nitin A - Award D 306,433
2026-04-21 SNYR / Synergy CHC Corp. 4 Thompson Teresa Brigid A - Award D 25,824
2026-04-10 FTLF / FitLife Brands, Inc. 4 Lingenbrink Matthew P - Purchase D 9.76 3,000
2026-04-10 FTLF / FitLife Brands, Inc. 4 Dawson Grant Robert P - Purchase D 9.98 3,000
2026-04-02 MRMD / MariMed Inc. 4 Levine Jon R M - Exercise D 11,518
2026-04-02 MRMD / MariMed Inc. 4 Shaw Timothy M - Exercise D 9,982
2026-04-02 MRMD / MariMed Inc. 4 Shaw Timothy F - Taxes D 0.0691 -3,459
2026-04-02 MRMD / MariMed Inc. 4 Levine Jon R F - Taxes D 0.0691 -3,992
2026-03-31 CGC / Canopy Growth Corporation 4 ATKINS M SHAN S - Sale D 0.93 -2,074
2026-03-31 CGC / Canopy Growth Corporation 4 Yanofsky Theresa S - Sale D 0.93 -10,373
2026-03-31 CGC / Canopy Growth Corporation 4 Lazzarato David Angelo S - Sale D 0.93 -15,624
2026-03-31 CGC / Canopy Growth Corporation 4 BAYERN JOSEPH S - Sale D 0.93 -2,658
2026-03-28 MRMD / MariMed Inc. 4 Crandall Ryan M - Exercise D 6,047
2026-03-28 MRMD / MariMed Inc. 4 Crandall Ryan F - Taxes D 0.0758 -2,096
2026-03-25 DFTX / Definium Therapeutics, Inc. 4 Barrow Robert S - Sale D 18.47 -24,431
2026-03-25 DFTX / Definium Therapeutics, Inc. 4 Karlin Dan S - Sale D 18.47 -8,018
2026-03-25 DFTX / Definium Therapeutics, Inc. 4 Sullivan Mark S - Sale D 18.47 -10,702
2026-03-20 USNA / USANA Health Sciences, Inc. 4 FULLER GILBERT A S - Sale D 17 -1,058
2026-03-19 CRON / Cronos Group Inc. 4 Shlimak Anna M - Exercise D 28,429
2026-03-19 CRON / Cronos Group Inc. 4 Shlimak Anna F - Taxes D 2.54 -9,767
2026-03-15 CRON / Cronos Group Inc. 4 GORENSTEIN MICHAEL RYAN M - Exercise D 324,540
2026-03-15 CRON / Cronos Group Inc. 4 JACOBSON JEFFREY DAVID M - Exercise D 59,191
2026-03-15 CRON / Cronos Group Inc. 4 Shlimak Anna M - Exercise D 45,226
2026-03-15 CRON / Cronos Group Inc. 4 Buggy Shannon M - Exercise D 20,938
2026-03-15 CRON / Cronos Group Inc. 4 Weigensberg Arye M - Exercise D 24,236
2026-03-15 CRON / Cronos Group Inc. 4 Doucet Terrence Gregory Joseph M - Exercise D 23,897
2026-03-15 CRON / Cronos Group Inc. 4 Doucet Terrence Gregory Joseph F - Taxes D 3.44 -12,276
2026-03-15 CRON / Cronos Group Inc. 4 GORENSTEIN MICHAEL RYAN F - Taxes D 2.50 -127,706
2026-03-15 CRON / Cronos Group Inc. 4 Shlimak Anna F - Taxes D 2.50 -16,354
2026-03-15 CRON / Cronos Group Inc. 4 Buggy Shannon F - Taxes D 2.50 -9,202
2026-03-15 CRON / Cronos Group Inc. 4 JACOBSON JEFFREY DAVID F - Taxes D 2.50 -22,552
2026-03-13 TCNNF / Trulieve Cannabis Corp. 4 Rivers Kim A. A - Award D 218,750
2026-03-13 TCNNF / Trulieve Cannabis Corp. 4 MORREAU JANE C A - Award D 23,438
2026-03-13 TCNNF / Trulieve Cannabis Corp. 4 Jhala Nilyum A - Award D 58,594
2026-03-13 TCNNF / Trulieve Cannabis Corp. 4 May Richard S. A - Award D 23,438
2026-03-13 TCNNF / Trulieve Cannabis Corp. 4 Landrum Kyle A - Award D 58,594
2026-03-13 TCNNF / Trulieve Cannabis Corp. 4 Walsh Brett R. A - Award D 28,711
2026-03-13 TCNNF / Trulieve Cannabis Corp. 4 Pernell Jason A - Award D 58,594
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)